|
× |
 |
A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Self-Harm Behaviors Among Buprenorphine-Treated Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Factors Associated With Health-Related Quality of Life Among Outpatients With Major Depressive Disorder: A STAR*D Report. PDF |
$40.00 |
|
$40.00 |
|
× |
|
When Nothing Stops Catatonia Except Electroconvulsive Therapy and Maybe A New Savior, Clozapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Six-Month Clinical and Ecological Momentary Assessment Follow-Up of Patients at High Risk of Suicide: A Survival Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Rapid and Non-Rapid Cycling Bipolar Disorder: A Meta-Analysis of Clinical Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Withdrawal-Emergent Dyskinesia Following Abrupt Discontinuation of Desvenlafaxine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Delayed Diagnosis of a Pituitary Prolactinoma PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of the COVID-19 Pandemic on Consultation-Liaison Psychiatry Services: An Exploratory Study From a Tertiary Care Center in North India PDF |
$40.00 |
|
$40.00 |
|
× |
|
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF |
$40.00 |
|
$40.00 |
|
× |
|
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Open Trial of Topiramate in the Treatment of Generalized Social Phobia PDF |
$40.00 |
|
$40.00 |
|
|
